Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2025-03-13 | 2025-03-28 | 252548 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2020-03-20 | 2020-04-24 | 109087 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2017-09-04 | 2017-11-20 | 20875 |
| APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2017-08-14 | 2017-12-07 | 19129 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2020-08-14 | 2020-11-18 | 122276 |
| APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2019-08-08 | 2020-06-24 | 91143 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2025-01-30 | 2025-04-11 | 249096 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-08-18 | 2023-09-12 | 202406 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2022-12-09 | 2023-01-31 | 177609 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180109 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-03-19 | 2021-06-07 | 136019 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2024-03-01 | 2024-03-29 | 221087 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-04-09 | 2021-05-01 | 137250 |
| APO-IBUPROFEN TAB 200MG | 200MG | TABLET | Resolved | 2019-02-24 | 2020-04-01 | 76717 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2024-01-12 | 2024-03-29 | 215967 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-04-14 | 2023-04-21 | 189638 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210733 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |